DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/tbkl99/global_overactive) has announced the addition of the "Global Overactive Bladder Epidemiology and Patient Flow Analysis - 2012" report to their offering.
This report provides insights into Overactive Bladder epidemiology, Overactive Bladder diagnosed patients, and Overactive Bladder treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Overactive Bladder derived from epidemiological analysis, percentage of patients diagnosed with Overactive Bladder, and percentage of patients treated with Overactive Bladder therapy.
The study helps executives estimate Overactive Bladder market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
The report provides estimates and forecasts of Overactive Bladder prevalence, Overactive Bladder diagnosis rate, and Overactive Bladder treatment rate for the period 2012-2019. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on collection and interpretation of data from registries, scientific journals and literatures, government databases and other secondary sources.
Key Features of the Report:
- Overactive Bladder: Disease Definition
- Overactive Bladder Patient Flow
- Overactive Bladder Prevalence
- Overactive Bladder Diagnosed Patients
- Overactive Bladder Treated Patients
For more information visit http://www.researchandmarkets.com/research/tbkl99/global_overactive